Concentric Medical, Inc. announced the full European launch of Trevo Pro 4 System. This next standard in Stentriever technology has an enhanced design to further promote clot integration across clot types in patients suffering an acute ischemic stroke.
The Trevo Pro 4 system is the next generation of Trevo Stentrievers from Concentric Medical and is used to remove thrombus in stroke patients. It has a unique wide-cell geometry allowing the clot to more easily incorporate in the device. This unique cell and strut architecture, coupled with its proven radial force profile, are designed to further enhance clot retrieval in all clot types with fewer passes of the device in the procedure.
The Trevo Pro 4 device was introduced to a limited number of leading stroke centres in the spring. Fifty cases were completed in an initial evaluation post CE mark with very positive feedback from clinicians in Europe.
"The Trevo Pro 4 System is a significant advance in the field of mechanical thrombectomy. I have had the opportunity to utilize this device in many procedures and have found the clot integration astonishing, regardless of the complexity of the clot. On many occasions I have achieved revascularization with one pass of the device," said Professor Olav Jansen, Head of Neuroradiology at Universitatsklinikum Schleswig-Holstein, Kiel, Germany.
Maria Sainz, president and CEO of Concentric Medical, also commented: "The Trevo Pro System has improved the predictability of the interventional stroke procedure for physicians. The device redefines the standard for success for physicians and patients. Concentric Medical is very proud to be able to offer the latest advancement in Trevo technology along with a full array of complementary tools for the entire stroke interventional procedure."
The Trevo System is an innovative, high-performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is the Trevo Retriever which introduces Stentriever technology, creating a new generation of retrieval devices to remove clots in acute stroke patients. Concentric Medical is the pioneer in developing devices for ischemic stroke intervention. Since 2002, Concentric Medical's devices have been used in thousands of stroke patients worldwide. This experience has been incorporated into the design of the Trevo System to make thrombus removal an easier, faster and more predictable procedure. The new Trevo System combined with the MerciRetriever, DAC (Distal Access Catheters) and Balloon Guide Catheter portfolio of products, further strengthens Concentric Medical's position as a global leader in acute ischemic stroke intervention.
Concentric Medical is located in Mountain View, California and is a global leader in the development of endovascular devices for revascularizing stroke patients. Concentric Medical's devices are available in over 500 leading stroke centres around the world, and have been the subject of several clinical studies.